Free Trial

Silence Therapeutics (SLNCF) SEC Filings & 10K Form

Silence Therapeutics logo
$2.00 0.00 (0.00%)
(As of 12/20/2024 ET)

Recent Silence Therapeutics SEC Filings

DateFilerForm TypeView
12/20/2024
4:32 PM
Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
12/09/2024
7:12 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
3:54 PM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
8:44 AM
Deep Track Capital, LP (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
11/14/2024
8:24 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
4:20 PM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form F-3ASR
08/15/2024
8:05 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
5:51 PM
Invus Global Management, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
06/27/2024
6:40 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:38 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
7:41 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
1:21 PM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
11:15 PM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form EFFECT
05/08/2024
4:14 PM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form DEL AM
05/01/2024
3:37 PM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
7:36 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
6:00 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
7:52 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/13/2024
6:10 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
7:12 AM
Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
8:54 AM
Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
02/14/2024
7:55 AM
Deep Track Capital, LP (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
02/12/2024
5:15 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
02/09/2024
4:05 PM
Artal International S.C.A. (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:SLNCF) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners